Özet:

Purpose: The work is planned to identify anxiety, insomnia and depression conditions in the COVID-19 epidemic of pharmacist staff with an important place in the presence of health services. Method: This study is a cutting-edge qualified survey study applied to all pharmacy employees in the center of the province during the COVID-19 epidemic. In this study, the survey form that contains demographic information to all participants was applied to the Common Anxiety Disorder-7 (YAB-7) Test, insomnia severity index and Patient Health Survey - 9 (PHQ - 9). Results: The study included 126 pharmacy employees, of which 45.2 percent were pharmacists and 54.8 percent were other employees. A significant part of the study group had anxiety (49.1 percent), depression (45.2 percent) and insomnia (52.4 percent). Previously, in those with a history of mental illness, fear of infection, increased workload, and those with a high chance of encountering the patient, anxiety, depression and insomnia rates have been significantly higher. The research group found no statistically significant differences in terms of anxiety, depression and insomnia compared to those who were not pharmacists. Results: The study found that during the COVID-19 pandemic, pharmaceutical workers developed an average level of anxiety, depression and insomnia. The fact that pharmaceutical employees have scale points close to the medical staff in the literature shows that there is an increase in risk in this group, although they do not work in the hospital. All planned psychosocial initiatives should be taken into account in the pharmacy staff working outside the hospital and providing health care.

Anahtar Kelimeler: